Psychedelicized: Acceptance of Utility of Psychedelics Prior to Adequate Data

Abstract

Get full access to this article

View all access options for this article.

References

Kucsera

Suppes

Haug

. Psychologists' and psychotherapists' knowledge, attitudes, and clinical practices regarding the therapeutic use of psychedelics. Clin Psychol Psychother. 2023;30(6):1369-1379. doi:10.1002/cpp.2880.

Pagán

Lex

Soares

Meyer

. Medical students' attitudes and beliefs toward psilocybin: does terminology and personal experience with psychedelics matter? Psychedelic Med (New Rochelle). 2023;1(3):130-138. doi:10.1089/psymed.2023.0022.

Wang

Mathai

Gukasyan

Nayak

Garcia-Romeu

. Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among U.S. healthcare professionals. Sci Rep. 2024;14(1):28022. doi:10.1038/s41598-024-78736-1.

Barnett

Arakelian

Beebe

, et al. American psychiatrists' opinions about classic hallucinogens and their potential therapeutic applications: a 7-year follow-up survey. Psychedelic Med (New Rochelle). 2024;2(1):1-9. doi:10.1089/psymed.2023.0036.

Nadeem

Parker

McGovern

Oestreich

. Attitudes toward psychedelics and psychedelic-assisted therapy among potential mental health service users and the general population in Australia. Aust N Z J Psychiatry. 2024;58(10):904-913. doi:10.1177/00048674241261779.